Literature DB >> 7214106

Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia.

V A Rao, M Bishop, A Coppen.   

Abstract

Chronic schizophrenic patients were maintained for six months on a dosage of haloperidol adjusted to give optimum clinical effect. A correlation was found between extrapyramidal symptoms and prolactin levels and also between plasma haloperidol concentration and plasma prolactin levels. Estimation of plasma prolactin would be a reliable measurement of patients' compliance with medication.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7214106     DOI： 10.1192/bjp.137.6.518

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  7 in total

1.  Hyperprolactinemia associated with risperidone: a case report and review of literature.

Authors:  Ahmed Aboraya; Jennifer E Fullen; Barbara L Ponieman; Eugene H Makela; Melissa Latocha
Journal:  Psychiatry (Edgmont)       Date:  2004-11

2.  Prolactin responses to haloperidol in drug-free and treated schizophrenic patients.

Authors:  M Markianos; G Sakellariou; E Bistolaki
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 3.  The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia.

Authors:  S Ulrich; C Wurthmann; M Brosz; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

4.  Antiemetic effect of haloperidol in the dog as related to plasma level and dose.

Authors:  C J Niemegeers; J J Heykants; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Haloperidol plasma levels and clinical response in paranoid schizophrenics.

Authors:  P Linkowski; P Hubain; R von Frenckell; J Mendlewicz
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

6.  Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.

Authors:  M L Rao; W A Brown
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 7.  Pharmacokinetics of haloperidol.

Authors:  J S Froemming; Y W Lam; M W Jann; C M Davis
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.